✅ Just Accepted
🔗 https://bit.ly/4nHVsw8
#PITT_IDFall25
#IDSky
#PITT_IDFall25
#IDSky
#PITT_IDFall25
Cloxacillin versus cefazolin for MSSA Bacteraemia
Cefazolin has a non-inferior efficacy regarding mortality, microbiological or clinical endpoints and was associated with a lower rate of serious adverse events #IDSky
www.thelancet.com/journals/lan...
#PITT_IDFall25
#PITT_IDFall25
Read the news here: bit.ly/3JgoNQ5
#PITT_IDFall25
#PITT_IDFall25
The immune response in children aged 2 to 11 years was non-inferior to that observed in adults, and 2.5-times greater in children aged 2 to 5.
www.cidrap.umn.edu/m...
Photo: Doc James / Wikimedia Commons
#PITT_IDFall25
#IDSky
#PITT_IDFall25
www.uptodate.com/contents/wha...
#PITT_IDFall25
www.uptodate.com/contents/wha...
#IDSky
#MedSky #Hematology
✅ Just Accepted
#IDSky
🔗 https://bit.ly/48tWCHo
✅ Just Accepted
https://bit.ly/4nru0mv
#IDSky
#MedSky
In our next event, experts will discuss the complex web of priorities behind AI models in health care.
Sign up: nejm.ai/41ZDYDl
Breakthroughs in molecular therapeutics & immunotherapies have improved treatment efficacy while reducing toxicity.
A recent Seminar provides an up-to-date overview: tinyurl.com/4v7fjm2f
✅ Just Accepted
https://bit.ly/426MyQH
✅ Just Accepted
https://bit.ly/426MyQH
Breakthroughs in molecular therapeutics & immunotherapies have improved treatment efficacy while reducing toxicity.
A recent Seminar provides an up-to-date overview: tinyurl.com/4v7fjm2f